{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T07:16:46Z","timestamp":1783322206396,"version":"3.54.6"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":177,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The field of immunology is increasingly intersecting with molecular biology, metabolic biology, and neurobiology (Zhu et al, A neuroimmune circuit mediates cancer cachexia-associated apathy. Science 2025;388:eadm8857; Jaschke et al, Gut-to-brain signaling restricts dietary protein intake during recovery from catabolic states. Cell 2025;188:7481\u20137494.e16; Zheremyan et al, Regulatory B cells: changing the landscape of immunoregulation and immunotherapy. Cytokine Growth Factor Rev 2025;86:121\u201336), marking a shift beyond traditional research approaches toward a more comprehensive understanding of the immune system. Central to this integrated perspective is the growing recognition that B cells are not only antibody producers, but also multifunctional cells dynamically modulated by their microenvironment. This comprehensive synthesis of recent research illuminates the dual nature of regulatory B cells (Bregs) as pivotal orchestrators of immune homeostasis. We examine how Bregs, governed by complex metabolic cues, neural signaling pathways, and local tissue microenvironments, can either suppress pathological inflammation or be co-opted to drive disease progression in autoimmunity, cancer, and allergic conditions. Understanding these microenvironmental determinants of Breg function is particularly critical for developing next-generation prognostic tools and targeted therapeutic strategies that effectively modulate B cell activity in various disease states.<\/jats:p>","DOI":"10.1093\/immadv\/ltag011","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:49:25Z","timestamp":1782388165000},"source":"Crossref","is-referenced-by-count":0,"title":["Harnessing the duality of regulatory B cells: from identification of characteristic molecules to therapeutic targeting"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0121-349X","authenticated-orcid":false,"given":"Luman","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Immunology, School of Basic Medical Sciences, Fudan University , Shanghai ,","place":["China"]},{"name":"Shanghai Fifth People\u2019s Hospital, Fudan University , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8096-769X","authenticated-orcid":false,"given":"Ronghua","family":"Liu","sequence":"additional","affiliation":[{"name":"Shanghai Fifth People\u2019s Hospital, Fudan University , Shanghai ,","place":["China"]},{"name":"Institutes of Biomedical Sciences, Fudan University , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-1111","authenticated-orcid":false,"given":"Yiwei","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Basic Medical Sciences, Fudan University , Shanghai ,","place":["China"]},{"name":"Shanghai Fifth People\u2019s Hospital, Fudan University , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"2026070603020715800_ltag011-B1","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.cmet.2021.05.008","article-title":"The emerging field of regulatory B cell immunometabolism","volume":"33","author":"Rosser","year":"2021","journal-title":"Cell Metab"},{"key":"2026070603020715800_ltag011-B2","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1111\/all.14763","article-title":"Regulatory B cells, A to Z","volume":"76","author":"Jansen","year":"2021","journal-title":"Allergy"},{"key":"2026070603020715800_ltag011-B3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/jleuko\/qiad066","article-title":"Insights into the roles of IL-10-producing regulatory B cells in cardiovascular disorders: recent advances and future perspectives","volume":"114","author":"Zheng","year":"2023","journal-title":"J Leukoc Biol"},{"key":"2026070603020715800_ltag011-B4","doi-asserted-by":"publisher","first-page":"1635178","DOI":"10.3389\/fimmu.2025.1635178","article-title":"Spatiotemporal regulation of ventilator lung injury resolution by TGF-\u03b21 + regulatory B cells via macrophage vesicle-nanotherapeutics","volume":"16","author":"Jing","year":"2025","journal-title":"Front Immunol"},{"key":"2026070603020715800_ltag011-B5","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00011-024-01925-1","article-title":"IL-35 promotes IL-35(+)IL-10(+) Bregs and conventional LAG3(+) tregs in the lung tissue of OVA-induced asthmatic mice","volume":"73","author":"Saheb Sharif-Askari","year":"2024","journal-title":"Inflamm Res"},{"key":"2026070603020715800_ltag011-B6","doi-asserted-by":"publisher","first-page":"ltaf010","DOI":"10.1093\/immadv\/ltaf010","article-title":"Abnormal glucose and lipid metabolism promotes disrupted differentiation of T and B cell subsets in Beh\u00e7et's disease","volume":"5","author":"Li","year":"2025","journal-title":"Immunother Adv"},{"key":"2026070603020715800_ltag011-B7","doi-asserted-by":"publisher","first-page":"ltaf007","DOI":"10.1093\/immadv\/ltaf007","article-title":"M2 macrophages promote IL-10(+)B-cell production and alleviate asthma in mice","volume":"5","author":"Yu","year":"2025","journal-title":"Immunother Adv"},{"key":"2026070603020715800_ltag011-B8","doi-asserted-by":"publisher","first-page":"ltaf012","DOI":"10.1093\/immadv\/ltaf012","article-title":"Intra-tumoural RAMP1+ B cells promote resistance to neoadjuvant anti-PD-1-based therapy in oesophageal squamous cell carcinoma","volume":"5","author":"Zhang","year":"2025","journal-title":"Immunother Adv"},{"key":"2026070603020715800_ltag011-B9","doi-asserted-by":"publisher","first-page":"ltaf020","DOI":"10.1093\/immadv\/ltaf020","article-title":"Heterogeneity of regulatory B cells in autoimmune diseases: implications for immune equilibrium and therapeutic strategies","volume":"5","author":"Yan","year":"2025","journal-title":"Immunother Adv"},{"key":"2026070603020715800_ltag011-B10","doi-asserted-by":"publisher","first-page":"ltaf013","DOI":"10.1093\/immadv\/ltaf013","article-title":"Regulatory B cells promote the immunosuppressive microenvironment and progression of clear cell renal cell carcinoma","volume":"5","author":"Ge","year":"2025","journal-title":"Immunother Adv"},{"key":"2026070603020715800_ltag011-B11","doi-asserted-by":"publisher","first-page":"ltaf029","DOI":"10.1093\/immadv\/ltaf029","article-title":"CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis","volume":"5","author":"Graham","year":"2025","journal-title":"Immunother Adv"}],"container-title":["Immunotherapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/immunotherapyadv\/advance-article-pdf\/doi\/10.1093\/immadv\/ltag011\/68627832\/ltag011.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/immunotherapyadv\/article-pdf\/6\/1\/ltag011\/68627832\/ltag011.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/immunotherapyadv\/article-pdf\/6\/1\/ltag011\/68627832\/ltag011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T07:02:12Z","timestamp":1783321332000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/immunotherapyadv\/article\/doi\/10.1093\/immadv\/ltag011\/8719004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"URL":"https:\/\/doi.org\/10.1093\/immadv\/ltag011","relation":{},"ISSN":["2732-4303"],"issn-type":[{"value":"2732-4303","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2025,12,31]]},"article-number":"ltag011"}}